Article

AJMC® in the Press, December 23, 2021

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece posted by Becker’s Hospital Review recapped a December 2021 article published in Evidence-Based Oncology™, the sister journal of The American Journal of Managed Care®. The article, “Leveraging Data and AI to Connect the Life Sciences, Health Systems,” covered the keynote address at Patient-Centered Oncology Care® 2021, in which Iksha Herr, MS, of Microsoft, discussed challenges in learning how to leverage artificial intelligence to process health care data and to drive insights that lead to better care delivery.

Related Videos
Dr Cesar Davila-Chapa
Milind Desai, MD
Masanori Aikawa, MD
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Cesar Davila-Chapa, MD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Krunal Patel, MD
Juan Carlos Martinez, MD
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Related Content
Test for AMD | Image credit: RFBSIP - stock.adobe.com
December 23rd 2024

Intravitreal Faricimab Associated With Increased Treatment Interval, Decreased CST

Julia Bonavitacola
Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated for neovascular age-related macular degeneration, best corrected visual acuity showed no sign of improvement.
Managed Care Cast
December 19th 2024

Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma

Giuliana Grossi
Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
A subpopulation of patients with CLL/SLL and secondary immunodeficiency disease carry increased infection risks | image credit: sdecoret - stock.adobe.com
December 19th 2024

Infection Rate More Than Double in CLL/SLL Accompanied By Secondary Immunodeficiency Disease

Karen Jacobson-Sive
Secondary immunodeficiency disease (SID) status was associated with significantly higher risk for severe bacterial infections in adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Managed Care Cast Presents: Navigating Burdens and Treatment Challenges of IPF
December 12th 2024

Managed Care Cast Presents: Navigating Burdens and Treatment Challenges of IPF

A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic pulmonary fibrosis (IPF).
Heart pulse, beat concept in atrial fibrillation | image credit: martialred - stock.adobe.com
December 19th 2024

Q&A: Dr Dan Bloomfield Elaborates on Novel Findings From AZALEA-TIMI 71 Trial, Future of FXI Inhibitor Abelacimab

Kyle Munz
Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, a factor XI (FXI) inhibitor, to reduce bleeding risk in atrial fibrillation treatment.
HIV | Image credit: fizkes - stock.adobe.com
December 19th 2024

Stigma Remains Primary Health Concern in Patients With HIV/AIDS

Julia Bonavitacola
Stigma surrounding HIV can lead to barriers to health care, including refusal to get care, that could help individuals who are living with the condition.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo